[go: up one dir, main page]

Antilla, 2023 - Google Patents

Improving Cardiac Delivery of Antisense Oligonucleotides With Peptidomimetic Targeting Agents

Antilla, 2023

View HTML
Document ID
7710094021727203804
Author
Antilla S
Publication year

External Links

Snippet

Cardiovascular disease (CVD) is one of the leading causes of death worldwide, both individually and as a comorbidity for other diseases such as diabetes and atherosclerosis. Unfortunately, CVD trends irreversibly toward heart failure. Current treatments only manage …
Continue reading at search.proquest.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Huang et al. RNA display methods for the discovery of bioactive macrocycles
Owens et al. MOrPH-PhD: an integrated phage display platform for the discovery of functional genetically encoded peptide macrocycles
Kamalinia et al. Directing evolution of novel ligands by mRNA display
Getz et al. Protease-resistant peptide ligands from a knottin scaffold library
Qi et al. Mirror-image protein and peptide drug discovery through mirror-image phage display
Peacock et al. Discovery of de novo macrocyclic peptides by messenger RNA display
EP2868744B1 (en) Screening method for peptide binding to target molecule in a ph-dependent manner
Berrade et al. Expressed protein ligation: a resourceful tool to study protein structure and function
Siang Ong et al. Recent advances in synthesis and identification of cyclic peptides for bioapplications
Goldflam et al. Recent advances toward the discovery of drug-like peptides de novo
Dietrich et al. Peptides as drugs: from screening to application
JP2015519344A (en) Translocation of non-natural chemical entities through the anthrax protective antigen pore
Rentero et al. Screening of large molecule diversities by phage display
WO2009067191A2 (en) Methods and compositions for the treatment of hepatitis c virus (hcv) infection
WO2011071280A9 (en) Intracelluar targeting bipodal peptide binder
Brown et al. Multiple synthetic routes to the mini-protein omomyc and coiled-coil domain truncations
Zhang et al. Rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2
Cheng et al. Enzymatic on-resin peptide cleavage and in situ cyclization one-pot strategy for the synthesis of cyclopeptide and cyclotide
Chen et al. Native peptide cyclization, sequential chemoselective amidation in water
Hayashi et al. Generating a mirror-image monobody targeting MCP-1 via TRAP display and chemical protein synthesis
EP3680335A1 (en) Peptides inhibiting klk1, klk4, or klk4 and klk8
Loktev et al. Multicyclic peptides as scaffolds for the development of tumor targeting agents
Antilla Improving Cardiac Delivery of Antisense Oligonucleotides With Peptidomimetic Targeting Agents
US11639369B2 (en) Ubiquitin high affinity cyclic peptides and methods of use thereof
Hooks et al. Development of homomultimers and heteromultimers of lung cancer‐specific peptoids